Yayınlar & Eserler

Yayın Ağı
Makaleler 8
Tümü (8)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (8)
ESCI (1)
Scopus (8)
TRDizin (1)

1. Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy

DEĞERLİ E., ŞENTÜRK ÖZTAŞ N., ALKAN G., Bedir S., Derin S., VALIKHANOVA N., et al.
JOURNAL OF CHEMOTHERAPY , cilt.35, sa.1, ss.29-38, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

Yekeduz E., Tural D., Erturk I., Karakaya S., EROL C., Ercelep O., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.148, sa.12, ss.3537-3546, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

3. The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

Yucel K. B., Yekeduz E., Karakaya S., Tural D., Erturk I., Erol C., et al.
SCIENTIFIC REPORTS , cilt.12, sa.1, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

4. Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme

DEĞERLİ E., ALKAN G., ŞENTÜRK ÖZTAŞ N., Bedir S., Derin S., DEMİRCİ N. S.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.3, ss.746-749, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

5. A single center's experience of the extrapulmonary neuroendocrine carcinomas

ÇELİK E., ŞENGÜL SAMANCI N., Derin S., Bedir S., DEĞERLİ E., ORUÇ K., et al.
NORTHERN CLINICS OF ISTANBUL , cilt.9, sa.1, ss.35-40, 2022 (ESCI, Scopus, TRDizin) identifier identifier identifier identifier

6. Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency

ÇELİK E., ŞENGÜL SAMANCI N., Karadag M., Demirci N. S., Cikman D. I., Derin S., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.7, ss.1665-1673, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience

Degerli E., Derin S., Oruc K., Sengul Samanci N., Bedir S., Celik E., et al.
JOURNAL OF MEDICAL VIROLOGY , cilt.93, sa.10, ss.5839-5845, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

Yekeduz E., Erturk I., Tural D., Karadurmus N., Karakaya S., Hizal M., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.6, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier
Metrikler

Yayın

9

Yayın (WoS)

8

Yayın (Scopus)

8

Atıf (WoS)

17

H-İndeks (WoS)

3

Atıf (Scopus)

22

H-İndeks (Scopus)

3

Atıf (Scholar)

12

H-İndeks (Scholar)

1

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları